ETFs Shandong Pharmaceutical Glass Co.Ltd

600529

CNE000001BG9

Non-Paper Containers & Packaging

End-of-day quote Shanghai S.E. 2026-10-27			5-day change	1st Jan Change
17.97 ^CNY	-1.70%		-2.50%	-9.83%

10-26	Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
09-18	Shandong Pharmaceutical Glass Seeks Up to 3.2 Billion Yuan from Private Placement	MT

ETFs positioned on Shandong Pharmaceutical Glass Co.Ltd

Name	YTD change	Weight	AuM
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+13.00%	-	9,273 M€
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+5.40%	-	37 M€
XTRACKERS EMERGING MARKETS CARBON REDUCTION AND CLIMATE IMPROVERS ETF - USD	+9.53%	0.01%	61 M€
BNY MELLON EMERGING MARKETS EQUITY ETF - USD	+14.13%	0.01%	89 M€
VANGUARD FTSE ASIA EX-JAPAN SHARES INDEX ETF - AUD	+7.71%	0.01%	535 M€
FRANKLIN FTSE CHINA ETF - USD	-17.98%	0.01%	338 M€
FRANKLIN FTSE CHINA UCITS ETF - ACC - USD	-14.26%	0%	1,754 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF ACC - USD	+15.29%	0%	117 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF DIST - USD	+13.37%	0%	24 M€
VANGUARD FTSE EMERGING MARKETS ALL CAP INDEX ETF - CAD	+8.09%	0%	3,276 M€
INVESCO FTSE ALL-WORLD UCITS ETF PFHDG ACC- EUR HEDGED	+11.91%	0%	69 M€
VANGUARD FTSE EMERGING MARKETS ETF - USD	+5.71%	0%	126,032 M€
VANGUARD FTSE EMERGING MARKETS SHARES ETF - AUD	-1.22%	0%	1,449 M€
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	+4.68%	0%	33,076 M€
VANGUARD FTSE EMERGING MARKETS UCITS ETF - USD	+5.25%	0%	3,667 M€
VANGUARD FTSE EMERGING MARKETS UCITS ETF ACCUMULATING - USD	+11.88%	0%	2,339 M€
INVESCO FTSE ALL-WORLD UCITS ETF PFHDG DIST - GBP HEDGED	+11.91%	0%	31 M€
INVESCO FTSE ALL-WORLD UCITS ETF - CHF HEDGED	+9.77%	0%	81 M€
INVESCO FTSE ALL-WORLD UCITS ETF DIST - USD	+16.99%	0%	331 M€
VANGUARD FTSE ALL-WORLD EX-US ETF - USD	+10.75%	0%	70,454 M€
STATE STREET SPDR GLOBAL ALLOCATION ETF - DISTRIBUTING - USD	+6.33%	0%	317 M€
VANGUARD TOTAL INTERNATIONAL STOCK ETF - USD	+10.42%	0%	163,510 M€
VANGUARD TOTAL WORLD STOCK ETF - USD	+11.79%	0%	81,610 M€
ELM MARKET NAVIGATOR ETF - USD	+7.37%	0%	594 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+13.08%	0%	1,674 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+15.29%	0%	12,086 M€
RETURN STACKED GLOBAL STOCKS & BONDS ETF - USD	+7.48%	0%	526 M€
VANGUARD FTSE GLOBAL ALL CAP EX CANADA INDEX ETF - CAD	+14.04%	0%	2,612 M€
CCM GLOBAL EQUITY ETF - USD	+14.04%	0%	1,199 M€
DEFINED DURATION 20 ETF - USD	+11.12%	0%	19 M€
THE BRINSMERE FUND GROWTH ETF - USD	+8.40%	0%	391 M€
RPAR RISK PARITY ETF - USD	+1.35%	0%	580 M€
VANGUARD BALANCED ETF PORTFOLIO - CAD	+7.22%	0%	4,204 M€
UPAR ULTRA RISK PARITY ETF - USD	-0.03%	0%	59 M€
VANGUARD GROWTH ETF PORTFOLIO - CAD	+10.72%	0%	7,793 M€
DISCIPLINE FUND ETF - USD	-.--%	0%	73 M€
THE BRINSMERE FUND CONSERVATIVE ETF - USD	+2.27%	0%	363 M€
NYLI HEDGE MULTI-STRATEGY TRACKER ETF - USD	+6.65%	0%	1,021 M€
VANGUARD CONSERVATIVE ETF PORTFOLIO - CAD	+3.76%	0%	688 M€
VANGUARD RETIREMENT INCOME ETF PORTFOLIO - CAD	+1.31%	0%	267 M€
CLEARSHARES OCIO ETF - DISTRIBUTING - USD	+8.30%	0%	176 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+13.01%	0%	62 M€

1 2

Shandong Pharmaceutical Glass Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceutical glass bottle products. The Company operates its businesses through five segments: the Packaging Products segment, the Trading segment, the Barreled Water segment, the Logistics segment and the Service segment. The Company's main glass bottle products include molded bottle series products, brown bottle series products, ampoules, and tube bottles. The Company's products also include butyl rubber plug products, aluminum-plastic caps, plastic bottle products and others. The Company's products are widely used in the packaging of various products such as medicines, health products, and cosmetics. The Company mainly operates its businesses in the domestic and overseas markets.

Employees

6,775

Sector

Non-Paper Containers & Packaging

Calendar

03:00am Earnings release - Q3 2026

More about the company